Conor Soravilla

Conor Soravilla has a diverse work experience in corporate development and strategy roles. Conor most recently served as the Director of Corporate Development at 3B Scientific starting in March 2023. Prior to that, they worked at U.S. Renal Care and Kyruus in similar roles, focusing on corporate development and strategy. From 2019 to 2021, they were employed at Surgical Care Affiliates in a corporate development and strategy position. Before transitioning into corporate development, Conor worked in investment banking at OEM Capital, specializing in technology investments. Conor also gained experience in private equity at Putnam Equities, LLC and real estate private equity at Workforce Partners. Earlier in their career, Conor worked as a research and trading summer analyst at DeMatteo Monness LLC and Morgan Stanley. Overall, Conor Soravilla brings extensive expertise in corporate development and strategy, backed by their diverse background in investment banking and private equity.

Conor Soravilla has a Bachelor of Science (B.Sc.) degree in Finance from Sacred Heart University. Additionally, they obtained the Series 79 certification from the Financial Industry Regulatory Authority (FINRA) in September 2016, and the Series 63 certification from FINRA in June 2016.